Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MVD | P53602 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | EYA2 | O00167 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16274513 | 0.85 | CRBN (0.32) | CRBN | |
| SCHEMBL26247427 | 0.80 | MEN1 (0.34) | MVD | |
| SCHEMBL9437064 | 0.78 | TDP1 (0.33) | MVDTDP1EYA2APPACE | |
| SCHEMBL3893329 | 0.77 | HDAC3 (0.38) | LMNA | |
| SCHEMBL17040289 | 0.76 | SMN1; SMN2 (0.35) | ACEKDM4ETSHR | |
| SCHEMBL9216352 | 0.75 | — | — | |
| SCHEMBL9426270 | 0.74 | CTSS (0.36) | TDP1 | |
| SCHEMBL14558869 | 0.73 | MVD (0.31) | MVDTDP1EYA2APPACE | |
| SCHEMBL14424094 | 0.73 | MVD (0.31) | MVDTDP1EYA2APPACE | |
| Water SCHEMBL27985983 | 0.73 | MVD (0.31) | MVDTDP1EYA2APPACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218555-A1 | CREATINE, ITS DERIVATIVES, COMPOSITIONS AND METHODS OF USE THEREOF | YU RUEY J (US) | 2023-07-13 | — | — | US | claimed |
| US-11642328-B2 | Creatine, its derivatives, compositions and methods of use thereof | YU RUEY J (US) | 2023-05-09 | — | — | US | claimed |
| US-9642825-B2 | Bio-available N-acetyl creatine species and compositions thereof | ENERGY BEVERAGES LLC | 2017-05-09 | — | — | US | claimed |
| US-20150238453-A1 | BIO-AVAILABLE N-ACETYL CREATINE SPECIES AND COMPOSITIONS THEREOF | 4141 HOLDINGS, LLC (US) | 2015-08-27 | — | — | US | claimed |
| US-8476223-B2 | Metallo-lactoferrin-coenzyme compositions to improve sleep patterns | NAIDU LP (US) | 2013-07-02 | — | — | US | claimed |
| US-20110200575-A1 | METALLO-LACTOFERRIN-COENZYME COMPOSITIONS TO IMPROVE SLEEP PATTERNS | NAIDU LP (US) | 2011-08-18 | — | — | US | claimed |
| US-7956031-B2 | Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy | NAIDU LP (US) | 2011-06-07 | — | — | US | claimed |
| US-20070253941-A1 | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof | NAIDU LP | 2007-11-01 | — | — | US | claimed |
| US-20060269535-A1 | Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy | NAIDU LP | 2006-11-30 | — | — | US | claimed |
| US-11813237-B2 | Creatine, its derivatives, compositions and methods of use thereof | YU RUEY J (US) | 2023-11-14 | — | — | US | disclosed |
| US-20230218555-A1 | CREATINE, ITS DERIVATIVES, COMPOSITIONS AND METHODS OF USE THEREOF | YU RUEY J (US) | 2023-07-13 | — | — | US | disclosed |
| US-11642328-B2 | Creatine, its derivatives, compositions and methods of use thereof | YU RUEY J (US) | 2023-05-09 | — | — | US | disclosed |
| US-20220401398-A1 | CREATINE, ITS DERIVATIVES, COMPOSITIONS AND METHODS OF USE THEREOF | YU RUEY J (US) | 2022-12-22 | — | — | US | disclosed |
| US-20220323388-A1 | CREATINE, ITS DERIVATIVES, COMPOSITIONS AND METHODS OF USE THEREOF | YU RUEY J (US) | 2022-10-13 | — | — | US | disclosed |
| US-20110286986-A1 | LACTOFERRIN AND ANGIOGENIN COMPOSITIONS AND USES THEREOF | NAIDU LP (US) | 2011-11-24 | — | — | US | disclosed |
| US-8021659-B2 | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof | NAIDU LP (US) | 2011-09-20 | — | — | US | disclosed |
| US-20110200575-A1 | METALLO-LACTOFERRIN-COENZYME COMPOSITIONS TO IMPROVE SLEEP PATTERNS | NAIDU LP (US) | 2011-08-18 | — | — | US | disclosed |
| US-7956031-B2 | Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy | NAIDU LP (US) | 2011-06-07 | — | — | US | disclosed |
| US-20070253941-A1 | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof | NAIDU LP | 2007-11-01 | — | — | US | disclosed |
| US-20060269535-A1 | Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy | NAIDU LP | 2006-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150238453-A1 | BIO-AVAILABLE N-ACETYL CREATINE SPECIES AND COMPOSITIONS THEREOF | CKMT1A; CKMT1B, RIMKLA, CRAT | MVD 4668/4885TDP1 3222/4885EYA2 4843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.